The company, which focuses on developing specialized treatments for rare disorders, will host the call through its investor relations portal. Stakeholders looking to join the discussion live can access the webcast via the Events & Presentations section of the corporate website. For those preferring telephone participation, registration is required in advance to secure individual dial-in credentials.
Following the live presentation, a digital replay will remain accessible on the company’s site for 30 days. PTC Therapeutics currently maintains a diverse clinical pipeline aimed at addressing unmet medical needs in both pediatric and adult patient populations, leveraging its global commercial infrastructure to support its portfolio of differentiated medicines.
Comments (0)
No comments yet. Be the first!